Immunovant, Inc.
IMVT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001764013
In the last 90 days, Immunovant, Inc. insiders filed 0 open-market purchases and 9 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $4.25B in total; Greenlight Capital is the only superinvestor holding it.
Holders of 5% or more of IMVT
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Immunovant, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Roivant Sciences Ltd. | 13D/A | 55.90%113.3M shares | −1.00 ppfrom 56.90% | Mar 8, 20216 filings | Dec 12, 2025 | SEC |
| FMR LLC | 13G/A | 8.40%14.7M shares | −1.70 ppfrom 10.10% | Feb 9, 20244 filings | Nov 5, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
18 Schedule 13D and 13G filings on Immunovant, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 20268:27 AM ET | Deep Track Capital, LPand 2 others | 13G/A | 4.55%9.34M shares | −1.04 ppfrom 5.59%Below 5% | Jun 30, 2026 | SEC |
| Dec 12, 20255:20 PM ET | Roivant Sciences Ltd. | 13D/A | 55.90%113.3M shares | −1.00 ppfrom 56.90% | Dec 12, 2025 | SEC |
| Nov 5, 202511:35 AM ET | FMR LLCand 1 other | 13G/A | 8.40%14.7M shares | −1.70 ppfrom 10.10% | Sep 30, 2025 | SEC |
| Apr 21, 20257:54 AM ET | Roivant Sciences Ltd. | 13D/A | 56.90%96.7M shares | 0.00 ppfrom 56.90% | Apr 21, 2025 | SEC |
| Mar 26, 20254:09 PM ET | Deep Track Capital, LPand 2 others | 13G | 5.59%9.50M shares | – | Mar 19, 2025 | SEC |
| Mar 7, 202510:01 AM ET | FMR LLCand 1 other | 13G/A | 10.10%17.1M shares | – | Feb 28, 2025 | SEC |
| Jan 15, 20254:30 PM ET | Roivant Sciences Ltd. | 13D/A | 56.90%96.7M shares | – | Jan 13, 2025 | SEC |
| Nov 12, 2024 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Deep Track Capital, LP | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2024 | FMR LLC | 13GOld format | – | New | – | SEC |
| Oct 4, 2023 | Roivant Sciences Ltd. | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Deep Track Capital, LP | 13G/AOld format | – | – | – | SEC |
| Dec 5, 2022 | RTW Investments, LP | 13G/AOld format | – | – | – | SEC |
| Dec 2, 2022 | RTW Investments, LP | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Deep Track Capital, LP | 13GOld format | – | New | – | SEC |
| Aug 2, 2021 | Roivant Sciences Ltd. | 13D/AOld format | – | – | – | SEC |
| Mar 8, 2021 | Roivant Sciences Ltd. | 13D/AOld format | – | – | – | SEC |
| Feb 16, 2021 | RTW Investments, LP | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
26 notices from officers, directors and other affiliates planning to sell Immunovant, Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Jun 26, 20264:25 PM ET | Jay S StoutOfficer | 40.0K | $1.53M | Jun 26, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 26, 20264:22 PM ET | Chris Adair Van TuylOfficer · Director | 17.8K | $682.8K | Jun 26, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 26, 20264:20 PM ET | Melanie GloriaOfficer | 17.7K | $678.6K | Jun 26, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 26, 20264:18 PM ET | Tiago GiraoOfficer | 10.0K | $384.6K | Jun 26, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 15, 20264:35 PM ET | Atul PandeDirector | 6.00K | $201.7K | Jun 15, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| May 28, 20264:12 PM ET | Andrew J FromkinDirector | 222.0K | $7.44M | May 28, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| May 20, 20264:37 PM ET | Atul PandeDirector | 6.00K | $157.7K | May 20, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| May 1, 20264:46 PM ET | Robert G SusmanDirector | 2.50K | $67.9K | May 1, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Feb 10, 20265:16 PM ET | Michael GeffnerOfficer | 5.80K | $155.2K | Feb 10, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Dec 1, 20254:35 PM ET | Andrew J FromkinDirector | 22.2K | $537.3K | Dec 1, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Dec 1, 20254:34 PM ET | Douglas HughesDirector | 15.0K | $362.3K | Dec 1, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Nov 26, 20255:07 PM ET | Michael GeffnerOfficer | 50.0K | $1.19M | Nov 26, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Nov 25, 20257:16 PM ET | Michael GeffnerOfficer | 103.9K | $2.43M | Nov 25, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 25, 20254:02 PM ET | William MaciasOfficer | 30.0K | $474.9K | Jun 25, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 13, 20255:34 PM ET | William MaciasOfficer | 50.0K | $778.5K | Jun 13, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 3, 20255:42 PM ET | William MaciasOfficer | 80.0K | $1.25M | Jun 3, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| May 21, 20254:24 PM ET | George V MigauskyFormer director | 21.8K | $318.0K | May 21, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| May 19, 20254:40 PM ET | George V MigauskyFormer director | 28.2K | $410.9K | May 19, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Mar 7, 20254:17 PM ET | Andrew J FromkinDirector | 8.00K | $156.2K | Mar 7, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Feb 14, 20254:11 PM ET | Mark S LevineFormer affiliate | 69.8K | $1.41M | Feb 14, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Feb 11, 20254:11 PM ET | Mark S LevineFormer affiliate | 29.2K | $570.4K | Feb 11, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Dec 2, 20244:33 PM ET | Douglas J. HughesOfficer | 5.42K | $153.0K | Dec 2, 202410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Dec 2, 20244:33 PM ET | Atul Chandra PandeDirector | 7.75K | $218.6K | Dec 2, 202410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Dec 1, 20234:20 PM ET | Atul Chandra PandeDirector | 12.3K | $483.3K | Dec 1, 202310b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Dec 1, 20234:19 PM ET | Andrew J FromkinDirector · Officer | 12.3K | $483.3K | Dec 1, 202310b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
Showing the latest 25. See the IMVT notices from the last 12 months